TherapeuticsMD, Inc. Stock

Equities

TXMD

US88338N2062

Pharmaceuticals

Market Closed - Nasdaq 04:00:00 2024-04-19 pm EDT 5-day change 1st Jan Change
1.86 USD -1.59% Intraday chart for TherapeuticsMD, Inc. -6.53% -17.33%
Sales 2022 69.96M Sales 2023 1.3M Capitalization 25.77M
Net income 2022 112M Net income 2023 -10M EV / Sales 2022 0.34 x
Net cash position 2022 29.31M Net Debt 2023 3.68M EV / Sales 2023 22.6 x
P/E ratio 2022
0.47 x
P/E ratio 2023
-2.28 x
Employees 1
Yield 2022 *
-
Yield 2023
-
Free-Float 96.22%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.59%
1 week-6.53%
Current month-18.78%
1 month-18.78%
3 months-16.63%
6 months-20.85%
Current year-17.33%
More quotes
1 week
1.86
Extreme 1.86
2.05
1 month
1.86
Extreme 1.86
2.40
Current year
1.86
Extreme 1.86
2.75
1 year
1.86
Extreme 1.86
4.73
3 years
1.86
Extreme 1.86
69.50
5 years
1.86
Extreme 1.86
234.50
10 years
1.86
Extreme 1.86
563.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 13-05-31
Director of Finance/CFO - 23-08-16
Corporate Officer/Principal - 18-02-28
Members of the board TitleAgeSince
Chairman 81 12-04-15
Director/Board Member 45 12-02-27
Director/Board Member 69 20-03-19
More insiders
Date Price Change Volume
24-04-18 1.89 0.00% 5,739
24-04-17 1.89 -0.53% 29,032
24-04-16 1.9 -2.56% 45,679
24-04-15 1.95 -2.01% 38,139
24-04-12 1.99 -4.33% 32,038

Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT

More quotes
TherapeuticsMD, Inc. is a healthcare company. The Company is focused on developing and commercializing products exclusively for women. It is engaged in conducting business by out-licensing its products and collecting royalties, after granting a license to commercialize the Company's IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands in the United States and its possessions and territories and assigning the Company’s exclusive license to commercialize ANNOVERA in the United States and its possessions and territories to Mayne Pharma. ANNOVERA is a one-year (13 cycles) ring-shaped contraceptive vaginal system (CVS)). ANNOVERA, which is made with a silicone elastomer, contains segesterone acetate, a 19-nor progesterone derivative also known as Nestorone (SA) and ethinyl estradiol (EE). Its menopause portfolio includes IMVEXXY and BIJUV. IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia.
More about the company